<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02253966</url>
  </required_header>
  <id_info>
    <org_study_id>H-3-2014-089</org_study_id>
    <nct_id>NCT02253966</nct_id>
  </id_info>
  <brief_title>Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lundbeck Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite improvements in analgesic treatment following total knee arthroplasty (TKA) for
      osteoarthrosis, a substantial part of patients still have severe acute pain after surgery. It
      has been suggested that preoperative degree of intraarticular inflammation is associated to
      postoperative degree of pain and level of function. Furthermore it is known, that patients
      with preoperative inflammation have hyperalgesia and severe movement related pain.

      The aim of this study is to investigate the effect of a preoperative intraarticular injection
      of Methylprednisoloneacetate in reducing acute postoperative pain after total knee
      arthroplasty in patients with signs of severe pre-operative inflammation and pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Pain intensity on a numeric rang scale (NRS) from 0 to 10 upon ambulation 24 hours following surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Pain intensity on a NRS from 0 to 10 upon ambulation 48 hours following</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>From day 1 to day 14</time_frame>
    <description>Diary-reported pain intensity on a NRS from 0 to 10 when walking. Once daily from first to fourteenth postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>From day 1 to day 14</time_frame>
    <description>Diary-reported pain intensity on a NRS from 0 to 10 upon rest. Once daily from first to fourteenth postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitisation</measure>
    <time_frame>On day 0 and day 2</time_frame>
    <description>Quantitative sensory testing (temporal summation / pressure algometry) on the day of surgery and on the second postoperative day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>On day 0 and day 2</time_frame>
    <description>Measurement of C-reactive protein in blood sample on the day of surgery and on the second postoperative day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>On day 0</time_frame>
    <description>Measurement of interleukin-6 level in knee joint fluid on the day of surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Knee Joint Osteoarthrosis</condition>
  <condition>Hyperalgesia</condition>
  <condition>Severe Movement Related Pain</condition>
  <arm_group>
    <arm_group_label>Methylprednisoloneacetate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of:
1 ml methylprednisoloneacetate 40 mg/ml 5 ml lidocaine 20 mg/ml 4 ml sodium chloride 9 mg/ml as a single intraarticular injection 7 days prior to surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium chloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of:
5 ml lidocaine 20 mg/ml 5 ml sodium chloride 9 mg/ml as a singe intraarticular injection 7 days prior to surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisoloneacetate</intervention_name>
    <arm_group_label>Methylprednisoloneacetate</arm_group_label>
    <other_name>Depo-Medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <arm_group_label>Methylprednisoloneacetate</arm_group_label>
    <arm_group_label>Sodium chloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <arm_group_label>Methylprednisoloneacetate</arm_group_label>
    <arm_group_label>Sodium chloride</arm_group_label>
    <other_name>saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 50 -80

          -  Osteoarthrosis

          -  Scheduled for primary unilateral TKA

          -  Preoperative pain report with NRS &gt; 5 upon walking

          -  Signs of sensitisation in knee

        Exclusion Criteria:

          -  Allergies to methylprednisoloneacetate, lidocaine or standard analgesic treatment

          -  Deficient written or spoken danish

          -  Impairment from psychological or neurological disease

          -  Local og systemic infection

          -  Immunodeficiency

          -  Treatment with corticosteroid within 30 days of inclusion

          -  Insulin treated diabetes mellitus

          -  Anticoagulant therapy

          -  ASA (American Society of Anaesthesia) class &gt; 3

          -  General anaesthesia

          -  Alchohol use &gt; 21 units / week

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gentofte Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2014</study_first_submitted>
  <study_first_submitted_qc>September 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2014</study_first_posted>
  <last_update_submitted>June 3, 2016</last_update_submitted>
  <last_update_submitted_qc>June 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Iben Engelund Luna</investigator_full_name>
    <investigator_title>MD, Research Fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

